SMarT Minds Dx
Affordable blood-based tests to detect and stage Alzheimer's disease
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
SMarT Minds Dx is an Australian diagnostics startup developing a scalable, affordable blood-based biomarker test for early detection, staging and treatment monitoring of Alzheimer's disease, built on proprietary antibodies and digital immunoassay platforms. Its products include the SMDx Detect p-Tau205 and SMDx Detect GFAP antibodies. It is one of 16 startups in UNSW Founders' 2026 10x Accelerator cohort, which each received a A$100,000 pre-seed investment.
- Website
- smartmindsdx.com.au
- Stage
- pre-seed
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagesmartmindsdx.com.au
For agents
Nothing listed yet.
Products
- SMDx Detect GFAP — Monoclonal antibody for measuring GFAP in plasma, CSF and tissue · Other
- SMDx Detect p-Tau205 — Monoclonal antibody for detecting p-Tau205, a marker of tau pathology · Other